BPC-157 cycling typically follows patterns of four to six weeks on, two to four weeks off
And we dont have long term data on these drugs
These classes are organized according to the protein sequence and structure
Surprisingly, glucagon, which is used to treat severe hypoglycemia by targeting the glucagon receptor and is a weak agonist for GLP-1R 26 , was also found to activate a subset of the pathways elicited by GLP-1 (7-36) stimulation 5 , underlining the importance of investigating polypharmacology
10.15386/cjmed-804 [DOI] [PMC free article] [PubMed] [Google Scholar] Christensen, M
Hence, because some of the cardiovascular benefits of SGLT2is are related to their hemodynamic effects, while those of GLP-1RAs are mainly related to their anti-atherogenic/anti-inflammatory actions, the two classes of medications may produce an additive cardiovascular benefit [11]